This makes postmenopausal women particularly susceptible to cancer thriving on lipid metabolism, and developing a further understanding of how PPARγ's activity is influenced by menopausal status can provide insight into developing targeted therapies for breast cancer prognosis across tumor subtypes. Here, PPARG is linked to neoplasm.